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ABSTRACT
A series of novel diselenides 5a–e were synthesized from -haloketones, -picoline alkenes and various secondary amines under
a dry nitrogen atmosphere. The structures of these compounds were established by means of their spectral data and they were
screened for scavenging activity against 1,1-diphenyl-2-picryl-hydrazyl (DPPH.). The results of this research showed that two of
these compounds (5e and 5d) exhibited reasonable antioxidant activity. The intermediate, methyl 5-methylindolizine-1-
carboxylate was prepared by condensation of methyl acrylate with 1-(carboxymethyl)-2-methylpyridinium halide, which was
prepared from -picoline and chloroacetic acid by using the Tschischibabin reaction.
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1. Introduction
Aerobic cells are inevitably exposed to reactive oxygen species
(ROS) formed as oxygen metabolites.1 ROS such as hydrogen
peroxide (H2O2), hydroxyl radical (HO
.) and superoxide anion
(O2
–.) may degenerate various biomacromolecules (DNA and
proteins), resulting in oxidative and genotoxic stress.2–4 Biologi-
cal systems use enzymatic (glutathione peroxidase, thioredoxin
reductase superoxide dismutase, etc.) and nonenzymatic (uric
acid, creatinine, polyamine, retinal, etc.) antioxidant systems
to prevent oxidative stress. However, once the systems are
disturbed the uncontrolled oxidative stresses initiate a series of
harmful biochemical events, or generate them as a consequence
of earlier tissue injury, thus aggravating the final damages. Such
damages include brain dysfunction, cancer, cardiovascular
disease and inflammation.5,6
Glutathione peroxidases (GPx) are antioxidant selenoenzymes
protecting various organisms from oxidative stresses by
catalysing the reduction of hydroperoxides at the expense of
glutathione.7,8 After the discovery of selenium as selenocysteine
(SeCys) in the active site of GPx,9,10 there has been a growing
interest in the biochemistry of selenium. Other selenium-
containing enzymes have been identified recently.11,12 X-ray
diffraction studies on GPx have shown that the two nitrogen
atoms of Gln-70 and Trp-148 are located very near the selenium
atom of SeCys-35 in the active site.13,14 Based on this observation,
various organoselenium compounds containing other hetero-
atoms have been synthesized to mimic the active site of GPx.15–21
In the present study, we have synthesized 3,3’-diselenobis(N,N-
disubstituted-indolizine-1-carboxamide) derivatives and have
investigated their antioxidant activity.
2. Experimental
Melting points were determined by using the open capillary
method and are uncorrected. All the reactions were run under
nitrogen atmosphere to prevent oxidation and the formation
of oxygen-sensitive selenide ions and selenium-containing
products. The purity of the compounds was routinely checked
by TLC on silica gel plates using 20 % EtOAc in petroleum ether
(60–90 °C) 1:4 solvent systems. IR spectra (in KBr) were recorded
on a Perkin Elmer FTIR spectrometer and 1H NMR spectra (in
CDCl3) were recorded on a Bruker 200 Spectrospin spectrometer.
2.1. Synthesis of Methyl 5-Methylindolizine-1-carboxylate22 (3)
A suspension of 1-(carboxymethyl)-2-methylpyridinium halide
(2, 10 mmol), methyl acrylate (50 mmol), triethyl amine (1.5 mL)
and MnO2 (80 mmol) in toluene (80 mL) was refluxed and stirred
for 5 h (monitored by TLC). The reaction mixture was then
cooled to room temperature, filtered and washed with acetone.
The combined filtrates were evaporated to yield a residue 3,
which was purified by column chromatography (silica gel, 20 %
EtOAc in petroleum ether (60–90 °C), yield 60 %, δH (200 MHz,
DMSO-d6) 2.3 (3H, s, CH3), 3.8 (3H, s, OCH3), 6.5 (1H, t, CH), 6.7
(1H, t, CH), 7.5 (1H, d, CH), 7.9 (1H, d, CH) and 8.1 ppm (1H, d,
CH); δC (75 MHz, DMSO-d6)162.8, 132.1, 130.2, 119.0, 117.9, 110.8,
64.4 and 19.3 ppm; (Found: C, 69.83; H, 5.86; N, 7.40; O, 16.91 %;
Calc. for C11H11NO2 (189.00): C, 70.03; H, 5.25; N, 6.98; O, 17.15 %).
2.2. General Procedure: Synthesis of 3,3’-Diselanediylbis
(5-methyl-N,N-substituted indolizine-1-carboxamide) (5a–e)
To a solution of indolizine derivative (1.75 mL, 1.79 g, 10 mmol)
in dry hexane (50 mL) was added a 1.6 mol L–1 solution of
n-BuLi in hexane (6.8 mL, 11 mmol). After 1 h of stirring at room
temperature, a white precipitate of the lithiated compound was
obtained. The supernatant solvent was removed with a syringe.
The white precipitate was dissolved in dry THF, the solution was
cooled to 0 °C and selenium powder (0.8 g, 10 mmol) was added.
Stirring was continued for an additional 1 h at 0 °C and 4 h at
room temperature. The resulting solution was filtered through
celite, and the solvent was evaporated to give a diselenide 5a
(1.29 g, 45 %). The presence of selenium metal was determined
from atomic absorption and 77Se NMR.
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2.2.1. Synthesis of 3,3’-Diselanediylbis(N,N,5-trimethylindolizine-1-
carboxamide) (5a)
M. p.: 167–168 °C; IR (KBr): 1210 (C-N amide), 1552 (C=C),
1635 cm–1 (C=O). δH (200 MHz, CDCl3): 2.3 (3H, s, CH3), 2.9 (6H, s,
CH3), 6.2 (1H, d, CH), 6.4 (1H, d, CH) and 8.35 ppm (1H, t, CH);
δC (75 MHz, CDCl3): 168.8, 132.3, 117.4, 116.2, 112.2, 37.5 and
20.2 ppm; (Found: C, 50.90; H, 4.98; N, 9.32; O, 5.00 %; Calc. for
C24H26N4O2Se2 (560.00); C, 51.44; H, 4.68; N, 10.00; O, 5.71 %).
Atomic absorption Se-27.25 %. 77Se NMR (CDCl3) δ 897 ppm. MS
(m/z): 560 (M+).
2.2.2. Synthesis of 3,3’-Diselanediylbis(N-ethyl-5-methylindolizine-
1- carboxamide) (5b)
M. p.: 154–155 °C; IR (KBr): 1210 (C-N amide), 1546 (C=C), 1627
(C=O), 3366 cm–1 (N-H amide). δH (200 MHz, CDCl3): 1.0 (3H, t,
CH3), 2.35 (3H, s, CH3), 3.0 (3H, s, CH3), 6.0 (1H, d, CH), 6.3 (1H, d,
CH), 8.3 (1H, t, CH) and 8.5 ppm (1H, d, H); δC (75 MHz, CDCl3):
163.9, 133.3, 118.4, 116.9, 111.0, 34.5, 19.2 and 15.0 ppm; (Found:
C, 50.00; H, 4.25; N, 9.02; O, 4.85 %; Calc. for C24H26N4O2Se2
(559.75.): C, 51.44; H, 4.68; N, 10.00; O, 5.71 %). Atomic absorption
Se-26.85 %. 77Se NMR (CDCl3) δ 796 ppm. MS (m/z): 558 (M
+).
2.2.3. Synthesis of 3,3’-Diselanediylbis(N,5-dimethylindolizine-1-
carboxamide) (5c)
M. p.: 205–208 °C; IR (KBr): 1221 (C-N amide), 1580 (C=C), 1666
(C=O), 3359 cm–1 (N-H amide). δH (200 MHz, CDCl3): 2.4 (3H, s,
CH3), 2.85 (3H, s, CH3), 6.3 (1H, d, CH), 6.5 (1H, d, CH), 8.4 (1H, s,
H) and 8.5 ppm (1H, t, CH) ; δC (75 MHz, CDCl3): 167.8, 132.1,
117.1, 116.8, 111.2, 26.5 and 19.6 ppm; (Found: C, 48.54; H, 4.00; N,
9.91; O, 6.52 %; Calc. for C22H22N4O2Se2 (532.36): C, 49.64; H, 4.17;
N, 10.52; O, 6.01 %). Atomic absorption Se-28.21 %. 77Se NMR
(95.3 MHz) δ 960.3 ppm. MS (m/z): 532 (M+).
2.2.4. Synthesis of 3,3’-Diselanediylbis(N,5-dimethyl-N-phenyl-
indolizine-1-carboxamide) (5d)
M. p.: 192–193 °C; IR (KBr): 1226 (C-N amide), 1556 (C=C),
1671 cm–1 (C=O). δH (200 MHz, CDCl3): 2.35 (3H, s, CH3), 6.1 (1H,
d, CH), 6.3 (1H, d , CH), 7.4 (5H, m, C6H5), 8.0 (1H, t, CH) and
10.0 ppm (1H, s, H); δC (75 MHz, CDCl3): 164.5, 137.9, 131.3, 128.9,
128.0, 121.6, 118.8, 117.6, 110.3 and 20.6 ppm; (Found: C, 57.94; H,
4.99; N, 7.23; O, 4.17 %; Calc. for C32H26N4O2Se2 (656.49): C, 58.54;
H, 3.99; N, 8.53; O, 4.87 %). 77Se NMR (95.3 MHz) δ 796 ppm.
Atomic absorption Se-24.66 %. MS (m/z): 654 (M+).
2.2.5. Synthesis of 3,3’-Diselanediylbis(5-methyl-N-nitro-N-phenyl-
indolizine-1-carboxamide) (5e)
M. p.: 223–224 °C; IR (KBr): 1226 (C-N amide), 1588 (C=C), 1671
cm–1 (C=O). δH (200 MHz, CDCl3): 2.1 (3H, s, CH3), 6.4 (1H, d,
CH), 6.6 (1H, d, CH), 7.6 (5H, m, C6H5) and 7.8 ppm (1H, t, CH);
δC (75 MHz, CDCl3): 137.3, 133.3, 131.4, 128.9, 128.0, 124.6, 117.1,
117.4, 111.5 and 19.5 ppm; (Found: C, 50.21; H, 4.11; N, 10.63; O,
10.17 %; Calc. for C32H24N6O6Se2 (746.49): C, 51.49; H, 3.24; N,
11.26; O, 12.86 %). Atomic absorption Se-22.03 %. 77Se NMR
(95.3 MHz) δ 742 ppm. MS (m/z): 746 (M+).
3. Pharmacological Activity
3.1. Determination of Radical Scavenging Activity using the
DPPH. Method
DPPH. assay is the simplest method to measure the ability of
antioxidants to intercept free radicals. Antioxidants react with
DPPH., which is a stable free radical, then scavenge this radical
by converting it to 1,1-diphenyl-2-picryl hydrazine due to their
H-donating ability. The degree of discoloration indicates the
scavenging potential of the antioxidant compounds. The experi-
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Scheme 1
Synthesis of diselenide derivatives.
mental procedure was adapted from Kumazawa et al.23 To 1.0 mL
of DPPH. (0.25 mmol L–1) in methanol was added 2.0 mL of the
varying concentrations of the test samples (250, 125, 50, 25, 10, 5,
2 and 1 µg mL–1). The reaction mixture was then allowed to stand
at room temperature in a dark chamber for 30 min. The change in
colour from deep violet to light yellow was measured at 514 nm
using a spectrophotometer. Methanol was used as a blank
solvent and a fresh DPPH. solution in methanol served as the
control. The percentage of remaining DPPH. was calculated
(Table 1), and the radical-scavenging effects of the tested
compounds were compared in terms of IC50 (the concentration
needed to reduce 50 % of the initial amount of DPPH. which was
expressed as the molar ratio of each compound to the radical).
The decrease in absorbance was then converted to percentage
antioxidant activity (AA%) using the equation:
AA% = 100 – {[(Abssample – Absblank) × 100]/Abscontrol}
blank = methanol (1.0 mL) plus sample solution (2.0 mL),
negative control = DPPH. solution (1.0 mL, 0.25 mmol L–1) plus
methanol (2.0 mL). Ascorbic acid was used as positive control.
IC50 is defined as the concentration sufficient to elicit 50 % of a
maximum effect estimate in 100 %.
4. Results and Discussion
In an effort to develop a novel antioxidant, a series of
3,3’-diselanediylbis (N,N-disubstituted indolizine-1-carboxamide)
derivatives were synthesized and evaluated for their antioxi-
dant activities. Compounds 5a–e were synthesized from
indolizine-1-carboxamide by treating it with n-butyl lithium and
selenium powder and characterized by physical and spectral
analysis. These compounds were screened for their scavenging
activity against 1,1-diphenyl-2-picryl-hydrazyl (DPPH.). DPPH.
tests the ability of a compound to act as donor for hydrogen
atoms or electrons, which was measured spectrophotometri-
cally and listed in Table 1. Recently, a number of studies have
shown that di-indolylmethane derivatives, indolizine and
organoselenium compounds show promising antioxidant
activity.20,24,25 It has been reported that the introduction of coordi-
nating amino or other groups to the thiols would enhance the
GPx-like catalytic activity of ebselen and other related
organoselenium compounds.26,27 In this study various substitutions
were made to the nitrogen of the above-mentioned carboxamide
group. Among the diselenide derivatives (5a–e), the N-aryl
substituent exhibited higher antioxidant activity in comparison
with compounds bearing N-alkyl and N,N-dialkyl substituents.
This is true in the case of ebselen, where the experimental and
theoretical results suggest that the presence of a phenyl
substituent is important for the antioxidant activity. These find-
ings suggest that N-aryl substituents might be more important
for antioxidant activity than N-alkyl chains. This clearly revealed
that most of the compounds used in the study possess significant
DPPH. scavenging activity, in all cases even superior to ascorbic
acid. Compound 5e appears to be the best among those tested
having a nitrophenyl group. The presence of the polar group
NO2 led to an interesting modification of the pharmacological
properties. This may warrant further in-depth biological evalua-
tions. Work is in progress to design, synthesize and evaluate
additional compounds in this and related systems.
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Table 1 Antioxidant activities for DPPH. radical.
Compound DPPH. model IC50/mmol L
–1
5a 10.69 ± 0.50
5b 6.09 ± 0.24
5c 7.059 ± 0.30
5d 5.69 ± 0.55
5e 4.11 ± 0.05
Ascorbic acid 12.56 ± 0.50
